FibrosisLab

Study Protocol Builder

Select model, species, and dosing schedule to visualize your study design.

Study Configuration

1. Study Parameters

2. Treatment Settings

3. Endpoints & Analysis

General Condition

Biochemistry

Histology

Other

Study Timeline

Disease ModelBleomycin-induced Pulmonary Fibrosis
Day 0Induction
Day 7Start Dosing
Day 21Sacrifice
Daily Treatment (PO)

Analysis Plan

No endpoints selected.

Group Configuration

Total Animals: 0
GroupTreatmentNRouteFrequency

Reference Studies

Bleomycin model of pulmonary fibrosis

Moeller et al. (2008)

ReviewStandard Protocol